Cargando…

The Efficacy and Tolerability of ‘Polypills’: Meta-Analysis of Randomised Controlled Trials

BACKGROUND: To assess the blood pressure and lipid-lowering efficacy and tolerability of ‘polypills’ used in cardiovascular disease prevention trials. METHODOLOGY/PRINCIPAL FINDINGS: Systematic review and meta-analysis. Search strategy: The Cochrane Central Register of Controlled Trials, Medline, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elley, C Raina, Gupta, Ajay K., Webster, Ruth, Selak, Vanessa, Jun, Min, Patel, Anushka, Rodgers, Anthony, Thom, Simon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526586/ https://www.ncbi.nlm.nih.gov/pubmed/23284906 http://dx.doi.org/10.1371/journal.pone.0052145

Ejemplares similares

Recruiting equal numbers of indigenous and non-indigenous participants to a ‘polypill’ randomized trial
por: Selak, Vanessa, et al.
Publicado: (2013)

Process evaluation of the impact and acceptability of a polypill for prevention of cardiovascular disease
por: Wood, Frances, et al.
Publicado: (2015)

Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst Indigenous and non Indigenous people at high cardiovascular risk
por: Liu, Hueiming, et al.
Publicado: (2010)

Polypill—Friend or Foe?
por: Rishi, Rakesh Kumar
Publicado: (2011)

A protocol for an economic evaluation of a polypill in patients with established or at high risk of cardiovascular disease in a UK NHS setting: RUPEE (NHS) study
por: Crossan, Catriona, et al.
Publicado: (2018)

The Polypill: From Promise to Pragmatism
por: Huffman, Mark D.
Publicado: (2015)

Polypill revisited – Unity in diversity
por: Dan, Gheorghe-Andrei, et al.
Publicado: (2020)

Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia
por: Jung, Hae Won, et al.
Publicado: (2023)

Strengths and Limitations of Using the Polypill in Cardiovascular Prevention
por: Roy, Ambuj, et al.
Publicado: (2017)

Medicinal herbs: Potential polypills in cardiovascular diseases
por: Noroozi, Samaneh, et al.
Publicado: (2021)

The Benefits of Polypill: Adherence and Chronotherapy [Response to Letter]
por: Lopez-Jaramillo, Patricio, et al.
Publicado: (2023)

Polypills for Primary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis
por: Kandil, Omneya A., et al.
Publicado: (2022)

Statins alone or polypill for primary prevention of cardiovascular diseases
por: Hasani-Ranjbar, Shirin, et al.
Publicado: (2016)

Could patents interfere with the development of a cardiovascular polypill?
por: Beall, Reed F., et al.
Publicado: (2016)

The feasibility of polypill for cardiovascular disease prevention in Asian Population
por: Sukonthasarn, Apichard, et al.
Publicado: (2020)

Redefining the polypill: pros and cons in cardiovascular precision medicine
por: Birla, Siddharth, et al.
Publicado: (2023)

The Effectiveness of Polypill for the Prevention of Cardiovascular Disease: A Meta-Analysis of Randomized Controlled Trials
por: Virk, Ghazala S, et al.
Publicado: (2023)

„Polypill“ in der kardiovaskulären Prävention – erfolgreich durch Vereinfachung?: Neue Studienergebnisse zum Nutzen der Polypill-Strategie in der Primär- und Sekundärprävention
por: Despang, Patrick, et al.
Publicado: (2023)

Randomized Polypill Crossover Trial in People Aged 50 and Over
por: Wald, David S., et al.
Publicado: (2012)

Multifactorial Prevention of Cardiovascular Disease in Patients with Hypertension: the Cardiovascular Polypill
por: Lafeber, M., et al.
Publicado: (2016)

The polypill approach – An innovative strategy to improve cardiovascular health in Europe
por: Fuster, Valentín, et al.
Publicado: (2017)

Exercise on prescription for women aged 40-74 recruited through primary care: two year randomised controlled trial
por: Lawton, Beverley A, et al.
Publicado: (2008)

An International Randomised Placebo-Controlled Trial of a Four-Component Combination Pill (“Polypill”) in People with Raised Cardiovascular Risk
Publicado: (2011)

Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial
por: Mostaza, José M., et al.
Publicado: (2022)

The polypill in the primary prevention of cardiovascular disease: cost-effectiveness in the Dutch population
por: van Gils, Paul F, et al.
Publicado: (2011)

Prevention of Hypertensive Disorders of Pregnancy: a Novel Application of the Polypill Concept
por: Browne, J. L., et al.
Publicado: (2016)

Cost–benefit analysis of the polypill in the primary prevention of myocardial infarction and stroke
por: Wald, Nicholas J., et al.
Publicado: (2016)

Polypill eligibility and equivalent intake in a Swiss population-based study
por: Castioni, Julien, et al.
Publicado: (2021)

Practical Decision Algorithms for the Use of the Cardiovascular Polypill in Secondary Prevention in Europe
por: Grigorian-Shamagian, Lilian, et al.
Publicado: (2021)

Adoption and scale-up of the cardiovascular Polypill: a realist institutional analysis
por: Abimbola, Seye, et al.
Publicado: (2022)

Correction: An international randomised placebo-controlled trial of a four-component combination pill (“polypill”) in people with raised cardiovascular risk
Publicado: (2019)

Polypill for atherosclerotic cardiovascular disease prevention in Haiti: Eligibility estimates in a low-income country
por: Yan, Lily D., et al.
Publicado: (2022)

Safer Prescribing and Care for the Elderly (SPACE): a cluster randomised controlled trial in general practice
por: Wallis, Katharine A, et al.
Publicado: (2021)

Starting the polypill: the use of a single age cut-off in males and females
por: Wald, Nicholas J, et al.
Publicado: (2016)

Correlation of polypill and blood pressure level: A systematic review of clinical trials
por: Omrani, Hamidreza, et al.
Publicado: (2023)

A cardiovascular polypill for secondary stroke prevention in a tertiary centre in Ghana (SMAART): a phase 2 randomised clinical trial
por: Sarfo, Fred Stephen, et al.
Publicado: (2023)

Pragmatic Trials for Noncommunicable Diseases: Relieving Constraints
por: Patel, Anushka, et al.
Publicado: (2016)

A Polypill for primary prevention of cardiovascular disease: A feasibility study of the World Health Organization
por: Soliman, Elsayed Z, et al.
Publicado: (2011)

Does the Polypill Improve Patient Adherence Compared to Its Individual Formulations? A Systematic Review
por: Baumgartner, Ana, et al.
Publicado: (2020)

Polypill for Population-Level Primary Cardiovascular Prevention in Underserved Populations—A Social Epidemiology Counterargument
por: Cainzos-Achirica, Miguel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rv27m5mnbo4jncurp4ar07kurm